Publication | Closed Access

Silymarin ameliorates the disordered glucose metabolism of mice with diet-induced obesity by activating the hepatic SIRT1 pathway

ObesityMetabolic SyndromeMedicineLiver PhysiologyDiabetesPhysiologyDisordered Glucose MetabolismMetabolic RegulationHepatic Sirt1 PathwayFatty Liver DiseaseMetabolomicsMetabolismPharmacologyDiet-induced ObesityHealth Sciences